TY - JOUR
T1 - Limited effect of duration of CMV infection on adaptive immunity and frailty: insights from a 27-year-long longitudinal study
AU - Samson, Leonard Daniel
AU - van den Berg, Sara P. H.
AU - Engelfriet, Peter
AU - Boots, Annemieke M. H.
AU - Hendriks, Marion
AU - de Rond, Lia G. H.
AU - de Zeeuw-Brouwer, Mary-Iene
AU - Verschuren, W. M. Monique
AU - Borghans, Jose A. M.
AU - Buisman, Anne-Marie
AU - van Baarle, Debbie
N1 - Funding Information:
The Doetinchem Cohort Study is funded by the Dutch Ministry of Health, Welfare and Sport. Additional funding for the current study was also provided by the Ministry. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The graphical abstract image was created with BioRender.com. We thank Irina Tcherniaeva, Marjan Bogaard‐van Maurik, Ronald Jacobi and Gerco den Hartog for help with the CMV serology and Petra Vissink for the help with the longitudinal samples of the DCS.
Publisher Copyright:
© 2020 The Authors. Clinical & Translational Immunology published by John Wiley & Sons Australia, Ltd on behalf of Australian and New Zealand Society for Immunology, Inc.
Copyright:
Copyright 2020 Elsevier B.V., All rights reserved.
PY - 2020
Y1 - 2020
N2 - Objectives: Cytomegalovirus infection is thought to affect the immune system and to impact general health during ageing. Higher CMV-specific antibody levels in the elderly are generally assumed to reflect experienced viral reactivation during life. Furthermore, high levels of terminally differentiated and CMV-specific T cells are hallmarks of CMV infection, which are thought to expand over time, a process also referred to as memory inflation. Methods: We studied CMV-specific antibody levels over ~ 27 years in 268 individuals (aged 60–89 years at study endpoint), and to link duration of CMV infection to T-cell numbers, CMV-specific T-cell functions, frailty and cardiovascular disease at study endpoint. Results: In our study, 136/268 individuals were long-term CMV seropositive and 19 seroconverted during follow-up (seroconversion rate: 0.56%/year). CMV-specific antibody levels increased slightly over time. However, we did not find an association between duration of CMV infection and CMV-specific antibody levels at study endpoint. No clear association between duration of CMV infection and the size and function of the memory T-cell pool was observed. Elevated CMV-specific antibody levels were associated with the prevalence of cardiovascular disease but not with frailty. Age at CMV seroconversion was positively associated with CMV-specific antibody levels, memory CD4
+ T-cell numbers and frailty. Conclusion: Cytomegalovirus-specific memory T cells develop shortly after CMV seroconversion but do not seem to further increase over time. Age-related effects other than duration of CMV infection seem to contribute to CMV-induced changes in the immune system. Although CMV-specific immunity is not evidently linked to frailty, it tends to associate with higher prevalence of cardiovascular disease.
AB - Objectives: Cytomegalovirus infection is thought to affect the immune system and to impact general health during ageing. Higher CMV-specific antibody levels in the elderly are generally assumed to reflect experienced viral reactivation during life. Furthermore, high levels of terminally differentiated and CMV-specific T cells are hallmarks of CMV infection, which are thought to expand over time, a process also referred to as memory inflation. Methods: We studied CMV-specific antibody levels over ~ 27 years in 268 individuals (aged 60–89 years at study endpoint), and to link duration of CMV infection to T-cell numbers, CMV-specific T-cell functions, frailty and cardiovascular disease at study endpoint. Results: In our study, 136/268 individuals were long-term CMV seropositive and 19 seroconverted during follow-up (seroconversion rate: 0.56%/year). CMV-specific antibody levels increased slightly over time. However, we did not find an association between duration of CMV infection and CMV-specific antibody levels at study endpoint. No clear association between duration of CMV infection and the size and function of the memory T-cell pool was observed. Elevated CMV-specific antibody levels were associated with the prevalence of cardiovascular disease but not with frailty. Age at CMV seroconversion was positively associated with CMV-specific antibody levels, memory CD4
+ T-cell numbers and frailty. Conclusion: Cytomegalovirus-specific memory T cells develop shortly after CMV seroconversion but do not seem to further increase over time. Age-related effects other than duration of CMV infection seem to contribute to CMV-induced changes in the immune system. Although CMV-specific immunity is not evidently linked to frailty, it tends to associate with higher prevalence of cardiovascular disease.
KW - CMV-specific antibodies
KW - T-cell response
KW - ageing
KW - cardiovascular disease
KW - cytomegalovirus infection
KW - frailty
UR - http://www.scopus.com/inward/record.url?scp=85094103413&partnerID=8YFLogxK
U2 - 10.1002/cti2.1193
DO - 10.1002/cti2.1193
M3 - Article
C2 - 33133599
SN - 2050-0068
VL - 9
SP - 1
EP - 18
JO - Clinical & Translational Immunology (CTI)
JF - Clinical & Translational Immunology (CTI)
IS - 10
M1 - e1193
ER -